Compagnie Lombard Odier SCmA’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-57,560
Closed -$471K 625
2017
Q3
$471K Hold
57,560
0.02% 273
2017
Q2
$258K Hold
57,560
0.01% 328
2017
Q1
$317K Hold
57,560
0.01% 322
2016
Q4
$233K Hold
57,560
0.01% 426
2016
Q3
$406K Hold
57,560
0.01% 378
2016
Q2
$469K Hold
57,560
0.01% 346
2016
Q1
$468K Buy
57,560
+50,000
+661% +$407K 0.01% 348
2015
Q4
$91K Buy
+7,560
New +$91K ﹤0.01% 606